Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)
China · Delayed Price · Currency is CNY 27.96
-0.08 (-0.29%)
May 20, 2026, 1:15 PM CST
Shandong Wit Dyne Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,022 | 2,226 | 2,131 | 2,477 | 2,330 | 2,019 |
Other Revenue | 2.23 | 2.23 | 3.73 | 7.57 | 10.77 | 8.29 |
| 2,024 | 2,228 | 2,134 | 2,484 | 2,341 | 2,027 | |
Revenue Growth (YoY) | -7.10% | 4.40% | -14.08% | 6.11% | 15.49% | 11.32% |
Cost of Revenue | 330.2 | 339.81 | 343.65 | 339.11 | 502.67 | 630.37 |
Gross Profit | 1,694 | 1,889 | 1,791 | 2,145 | 1,838 | 1,397 |
Selling, General & Admin | 550.8 | 581.5 | 506.32 | 749.35 | 600.84 | 525.53 |
Research & Development | 95.47 | 91.1 | 101.43 | 95.59 | 65.59 | 80.45 |
Other Operating Expenses | 34.26 | 37.8 | 34.21 | 36.29 | 39.05 | 16.21 |
Operating Expenses | 681.86 | 711.73 | 642.22 | 888.83 | 705.04 | 619.88 |
Operating Income | 1,012 | 1,177 | 1,149 | 1,256 | 1,133 | 776.89 |
Interest Expense | - | - | - | -0.24 | -0.22 | - |
Interest & Investment Income | 46.75 | 45.13 | 47.62 | 42.56 | 17.95 | 39.83 |
Currency Exchange Gain (Loss) | - | - | -0.02 | 0.07 | 0.05 | -0.04 |
Other Non Operating Income (Expenses) | -15.68 | -11.14 | -1.26 | 2.39 | -0.01 | 5.47 |
EBT Excluding Unusual Items | 1,043 | 1,211 | 1,195 | 1,301 | 1,151 | 822.15 |
Impairment of Goodwill | - | - | - | - | - | 0.2 |
Gain (Loss) on Sale of Investments | 6.02 | 6.72 | 10.04 | 14.04 | 2.07 | 1.59 |
Gain (Loss) on Sale of Assets | 7.98 | 6.34 | - | 1.39 | - | -0.85 |
Asset Writedown | -16.41 | -21.45 | -43.89 | - | -0.88 | -0.13 |
Other Unusual Items | 4.57 | 4.57 | 17.1 | 8.97 | 6.87 | -1.84 |
Pretax Income | 1,046 | 1,207 | 1,178 | 1,325 | 1,159 | 821.12 |
Income Tax Expense | 153.39 | 178.45 | 172.19 | 198.3 | 161.3 | 116.82 |
Earnings From Continuing Operations | 892.12 | 1,029 | 1,006 | 1,127 | 997.89 | 704.3 |
Minority Interest in Earnings | -428.81 | -493.47 | -490.44 | -541.82 | -471.02 | -324.04 |
Net Income | 463.31 | 535.08 | 515.59 | 585.26 | 526.86 | 380.26 |
Net Income to Common | 463.31 | 535.08 | 515.59 | 585.26 | 526.86 | 380.26 |
Net Income Growth | -12.47% | 3.78% | -11.90% | 11.08% | 38.55% | 30.78% |
Shares Outstanding (Basic) | 235 | 235 | 234 | 234 | 234 | 235 |
Shares Outstanding (Diluted) | 235 | 235 | 234 | 234 | 234 | 235 |
Shares Change (YoY) | 0.34% | 0.14% | 0.11% | -0.02% | -0.24% | 0.11% |
EPS (Basic) | 1.97 | 2.28 | 2.20 | 2.50 | 2.25 | 1.62 |
EPS (Diluted) | 1.97 | 2.28 | 2.20 | 2.50 | 2.25 | 1.62 |
EPS Growth | -12.77% | 3.64% | -12.00% | 11.11% | 38.89% | 30.64% |
Free Cash Flow | 1,178 | 1,223 | 885.97 | 1,124 | 1,107 | 635.51 |
Free Cash Flow Per Share | 5.01 | 5.21 | 3.78 | 4.80 | 4.73 | 2.71 |
Dividend Per Share | 2.500 | 2.500 | 2.500 | 2.000 | 0.800 | 0.800 |
Dividend Growth | - | - | 25.00% | 150.00% | - | 128.57% |
Gross Margin | 83.69% | 84.75% | 83.90% | 86.35% | 78.53% | 68.90% |
Operating Margin | 50.01% | 52.81% | 53.81% | 50.57% | 48.41% | 38.32% |
Profit Margin | 22.89% | 24.01% | 24.15% | 23.56% | 22.50% | 18.76% |
Free Cash Flow Margin | 58.21% | 54.89% | 41.51% | 45.25% | 47.27% | 31.35% |
EBITDA | 1,082 | 1,247 | 1,222 | 1,330 | 1,202 | 846.14 |
EBITDA Margin | 53.46% | 55.98% | 57.25% | 53.52% | 51.33% | 41.74% |
D&A For EBITDA | 69.85 | 70.56 | 73.38 | 73.3 | 68.41 | 69.26 |
EBIT | 1,012 | 1,177 | 1,149 | 1,256 | 1,133 | 776.89 |
EBIT Margin | 50.01% | 52.81% | 53.81% | 50.57% | 48.41% | 38.32% |
Effective Tax Rate | 14.67% | 14.79% | 14.61% | 14.96% | 13.91% | 14.23% |
Revenue as Reported | 2,228 | 2,228 | 2,134 | 2,484 | - | - |
Advertising Expenses | - | 67.94 | 61.69 | 91.47 | 55.27 | 38.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.